Fundraising Fox

Sudhir Agrawal

Investor

Advisor at 82VS

Worcester, Massachusetts, United States

About

Sudhir Agrawal is founder and president of ARNAY Sciences LLC, a life science research practice specializing in the chemical engineering of oligonucleotides for RNA therapeutic applications. Over 35 years, his research has focused on discovering and developing RNA therapeutics, with work in gapmer antisense, exon skipping, and immune modulation through toll-like receptors. His recent research explores transient spatial cyclic structures of nucleic acids for RNA therapeutic development.

Experience

  1. ARNAY SciencesFounder and Presidentcurrent2017 β€” presentMassachusetts, United States
  2. Quiver BioscienceMember, Scientific Advisory Boardcurrent2024 β€” presentCambridge, MA
  3. Aldebaran TherapeuticsCo-Founder and scientific advisorcurrent2022 β€” presentUnited States
  4. Alloy Therapeutics, Inc.Chairman, Scientific Advisory Board, Genetic Medicinescurrent2022 β€” presentWaltham, Massachusetts, United States
  5. QurAlisMember, Scientific Advisory Boardcurrent2019 β€” present
  6. Dyne TherapeuticsMember, Scientific Advisory Boardcurrent2018 β€” present
  7. UMass Chan Medical SchoolAffiliate Professor in the Department of Medicinecurrent2021 β€” present
  8. UMass Chan Medical SchoolVisiting Professor in the Department of Medicine2018 β€” 2021Worcester, MA
  9. Harvard Medical School Initiative for RNA Medicine (HIRM)Member, Advisory Boardcurrent2017 β€” presentCambridge, MA
  10. SynGenisMember, Scientific Advisory Boardcurrent2021 β€” presentAustralia
  11. HAYA Therapeutics SAMember, Scientific Advisory Boardcurrent2021 β€” presentSwitzerland
  12. Bolden TherapeuticsScientific Advisor2020 β€” 2024Providence, Rhode Island, United States
  13. EnvisagenicsMember, Scientific Advisory Board2019 β€” 2024
  14. Maze TherapeuticsMember, Genetic therapy advisory board2021 β€” 2024
  15. Lytix BiopharmaMember, Scientific Advisory Board2018 β€” 2024Oslo Area, Norway
  16. Disarm Therapeutics (acquired by Lilly Company)Scientific Advisor2019 β€” 2022Cambridge, Massachusetts, United States
  17. Idera PharmaceuticalsPresident of Research2014 β€” 2017Cambridge, Massachusetts
  18. Idera PharmaceuticalsChief Executive Officer2004 β€” 2014Cambridge, Massachusetts
  19. Idera PharmaceuticalsChairman2010 β€” 2013Cambridge, Massachussetts
  20. Idera PharmaceuticalsChief Scientific Officer2000 β€” 2006Cambridge, Massachusetts

Education

  1. MRC Laboratory of Molecular Biology, Cambridge, UKPost Doctoral Research, Nucleic Acids1985 β€” 1986
  2. Allahabad University, IndiaM.Sc, D. Phil.1973 β€” 1980

Skills & more

Biotechnology12Life Sciences9Molecular Biology8Pharmaceutical IndustryDrug DiscoveryDrug Development5Clinical Development3OncologyCancer5Clinical Trials3Biochemistry2Organic Chemistry3
+5 moreLifesciencesVaccinesTechnology TransferBiopharmaceuticalsImmunology

From Sudhir's professional profile.

Shared employers

Colleagues at 82VS